BiotechTube
qPharmetra

qPharmetra

Boulder, United States· Est.
qpharmetra.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

qPharmetra is a US-based, private contract research organization (CRO) specializing in pharmacometric analysis and clinical pharmacology consulting. Founded in 2010 and headquartered in Boulder, Colorado, the company leverages a team of over 30 scientists in the US and Europe to support drug developers with data integration, modeling, and regulatory strategy. Its business model is service-based, generating revenue by providing expert analysis and proprietary software tools to pharmaceutical and biotech clients, positioning it as a specialized partner in the quantitative drug development space.

NeuroscienceHematologyPsychiatryGeneral Pharmacology

Technology Platform

Integrated pharmacometric analysis and clinical pharmacology expertise, supported by proprietary open-source software tools for automated data handling, modeling, and reporting workflows.

Opportunities

Growing regulatory and industry adoption of Model-Informed Drug Development (MIDD) creates strong demand for specialized pharmacometrics services.
The company can leverage its software tools to improve efficiency and create potential new productized revenue streams.
Expansion of services to support advanced therapies and complex trial designs presents further growth avenues.

Risk Factors

Revenue is dependent on client R&D budgets and is susceptible to biotech funding cycles.
High competition for specialized talent and from larger CROs building internal capabilities.
Business model carries client concentration risk and reliance on a project-based revenue stream without owned intellectual property in therapeutics.

Competitive Landscape

qPharmetra competes with specialized pharmacometrics consulting boutiques (e.g., Metrum Research Group, Cognigen) and the growing internal MIDD departments of large, full-service CROs (IQVIA, Parexel). Its differentiation lies in its deep scientific expertise, collaborative culture, and focus on tool-enabled consistency and reproducibility.

More companies in AI / Machine Learning →More companies in United States →